Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,772,427
+$6,518,633 QoQ
Shares Held
58,580
-0.8% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 419 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. KRYS ranks #20 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in KRYS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,772,427 | 58,580 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $15,253,794 | 59,050 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $15,621,019 | 63,361 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $11,618,320 | 65,815 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,401,300 | 68,393 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $11,991,571 | 66,509 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $10,876,119 | 69,425 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $12,060,397 | 66,255 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $11,861,122 | 64,589 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $3,478,530 | 19,550 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $2,368,553 | 19,092 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $2,265,132 | 19,527 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,196,083 | 18,706 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $740,474 | 9,249 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $564,046 | 7,120 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $485,460 | 6,965 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $431,910 | 6,578 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $434,705 | 6,533 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $431,101 | 6,163 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $292,114 | 5,595 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $188,972 | 2,779 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $205,696 | 2,670 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $143,340 | 2,389 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $102,845 | 2,389 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $113,655 | 2,744 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $106,845 | 2,471 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||